脂肪生成
脂肪肝
脂质代谢
CD36
脂肪变性
转录组
脂肪性肝炎
炎症
生物
血脂异常
促炎细胞因子
营养基因学
内分泌学
内科学
化学
基因表达
生物化学
疾病
医学
基因
糖尿病
作者
Shengjie Li,Yuna Wu,Haitao Jiang,Feng Zhou,Ailing Ben,Renlei Wang,Chun Hu
标识
DOI:10.1016/j.fshw.2022.03.025
摘要
Administration of chicory polysaccharides (CP) can modify lipid metabolism, improve dyslipidemia, and reduce liver inflammation, all of which may help alleviate non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanisms remain unclear. This study aimed to gain further understanding of the potential molecular mechanisms that mediate the protective effects of CP against NAFLD via transcriptomic and metabolomic analyses. Hepatic RNA-sequencing analysis demonstrated that long-term intake of CP restored expression of lipid metabolism-related genes Xbp1, Insig2, and Cth in NAFLD rats, thereby inhibiting de novo lipogenesis. Moreover, CP consumption restored expression levels of genes involved in pro-inflammatory responses, such as Irf1. In addition, metabolic data confirmed that CP treatment increased levels of L-palmitoylcarnitine and hexadecanoyl-CoA, implying that CP administration can promote hepatic fatty acid β-oxidation. The present results demonstrate the underlying mechanisms of CP in high-fat diet-induced NAFLD rats and suggest that CP treatment might provide a dietary therapeutic tool for the treatment of NAFLD in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI